1,149
Views
1
CrossRef citations to date
0
Altmetric
Editorials

Society of Pain And Palliative Care Pharmacists (SPPCP) Position Statement on the Proposed Change of Naloxone to Over-the-Counter (OTC) Status

Pages 1-5 | Received 09 Mar 2019, Accepted 28 Jul 2019, Published online: 23 Oct 2019

References

  • Xu J, Davis C, Cruz M, Lurie P. State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies. Drug Alcohol Depend. 2018;189:37–41. doi:10.1016/j.drugalcdep.2018.04.020.
  • Roberts AW, Carpenter DM, Smith A, Look KA. Reviewing state-mandated training requirements for naloxone-dispensing pharmacists. Res Social Adm Pharm. 2019;15(2):222–225. doi:10.1016/j.sapharm.2018.04.002.
  • Balick R. Patients can get and pharmacists can provide naloxone at the pharmacy. Why don’t they? Pharmacy Today August 2018.
  • Rando J, Broering D, Olson JE, Marco C, Evans SB. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33(9):1201–1204. doi:10.1016/j.ajem.2015.05.022.
  • FDA. Comprehension for OTC Naloxone (CONFER) Pivotal Label Comprehension Study – Task 3 Study Report. Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM629515.pdf. Accessed February 9, 2019.
  • Lenton S, Dietze P, Jauncey M. Australia reschedules naloxone for opioid overdose. Med J Aust. 2016;204(4):146–147. doi:10.5694/mja15.01181.
  • Walley A, Xuan Z, Hackman H, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174. doi:10.1136/bmj.f174.
  • Wulz JL, Sung H, Dugan DB, Wensel TM, Lander R, Manzella B. The pharmacist role in the development and implementation of a naloxone prescription program in Alabama. J Am Pharma Assoc. 2017;57(2):S141–S147. doi:10.1016/j.japh.2016.12.078.
  • Rafie S, Stone RH, Wilkinson TA, Borgelt L, El-Ibiary SY, Ragland D. Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects. IPRP. 2017;6:99–108. doi:10.2147/IPRP.S99541.
  • Cleland K, Bass J, Doci F, Foster AM. Access to emergency contraception in the over-the-counter era. Womens Health Issues. 2016;26(6):622–627. doi:10.1016/j.whi.2016.08.003.
  • Singer JA. To save lives, make naloxone an over-the-counter drug. Reason. April 2018.
  • Brody JE. Over-the-counter medicines’ benefits and dangers. The New York Times. December 2015; D5.
  • Gupta R, Shah ND, Ross JS. The rising price of Naloxone - Risks to Efforts to Stem Overdose Deaths. N Engl J Med. 2016;375(23):2213–2215. doi:10.1056/NEJMp1609578.
  • Rees DI, Sabia JJ, Argys LM, Latshaw J, Dave D. With a little help from my friends: the effects of naloxone access and good Samaritan laws on opioid-related deaths. NBER Working Paper No. 23171. Cambridge, MA: National Bureau of Economic Research; 2017. pp. 1–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.